![]()
nasdaq | Fluor Corporation and Align Technology have been highlighted as Zacks Bull and Bear of the Day |
insidermonkey | Verona Pharma plc Q4 2022 Earnings Call Transcript |
investopedia | Top Healthcare Stocks for March 2023 |
barrons | American Equity and Avis Budget Stock See Action From Activist Investors |
insidermonkey | 12 Best Performing NASDAQ Stocks in 2022 |
investors | Top-Notch Verona Pharma Scores A Win In COPD — And Hits A Four-Year High |
tipranks | These 2022 Winning Stocks Can Keep Soaring in 2023, Say Analysts |
investors | Here Are 10 Biotech Stocks — Including Catalyst And Viridian — That Would Have Netted You $10,000 More This Year |
bizjournals | Raleigh pharma raising $122M to prep for potential commercialization |
yahoo | Verona Pharma plc Announces Pricing of Upsized Underwritten Public Offering - Yahoo Finance |
fool | Why Verona Pharma Stock Is Skyrocketing Today |
yahoo | Verona Pharma Reports Second Quarter 2022 Financial Results and Provides Corporate Update - Yahoo Finance |
yahoo | Verona Pharma Reports Third Quarter 2021 Financial Results and Provides Corporate Update - Yahoo Finance |
yahoo | Verona Pharma Presents Pharmacokinetic Data with Ensifentrine at the European Respiratory Society International Congress 2021 - Yahoo Finance |
yahoo | Verona Pharma Reports Second Quarter 2021 Financial Results and Provides Corporate Update - Yahoo Finance |
yahoo | Verona Pharma Enters into $219M Ensifentrine Collaboration with Nuance Pharma |
yahoo | Verona Pharma Initiates Multiple Dose Part of Phase 2 Clinical Trial with pMDI Formulation of Ensifentrine in COPD - Yahoo Finance |
fool | Why Verona Pharma Stock Is Vaulting Higher Today |
zacks | Will Verona Pharma Continue to Surge Higher? |
benzinga | 82 Biggest Movers From Yesterday |
marketwatch | Verona Pharma shares shoot higher on Phase 2 trial of respiratory drug |
yahoo | Verona Pharma Appoints David Moskowitz as Vice President, Capital Markets Strategy & Investor Relations - Yahoo Finance |
benzinga | Riding December's Momentum Into 2020 |
yahoo | Here's Why We're Watching Verona Pharma's Cash Burn Situation |
